Farkas Charles, a director at CONMED Corp ($CNMD), sold shares on the open market three times over the past year, totaling about $335,000. His most recent CNMD insider sale occurred on September 12, 2025. These sales rank 7,336th among 11,678 individual insiders, far below the average of $8.6 million per seller and 6.4 transactions. Farkas Charles made no open market purchases of CNMD stock in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 12, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | S | Common Stock | 897 | $53.51 | 14,859.0000 | 31,150,000 | 5.69% | 0.00% |
| Sept. 12, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | S | Common Stock | 1103 | $53.54 | 15,756.0000 | 31,150,000 | 6.54% | 0.00% |
| June 2, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | A | RSUs (Restricted Stock Units) | 668 | $0.00 | 668.0000 | 31,150,000 | 9999.99% | 0.00% |
| June 3, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | M | RSUs (Restricted Stock Units) | 479 | $0.00 | 0.0000 | 31,150,000 | 100.00% | 0.00% |
| June 3, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | M | Common Stock | 479 | $0.00 | 16,859.0000 | 31,150,000 | 2.92% | 0.00% |
| June 2, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | A | Options To Purchase Common Stock | 8061 | $0.00 | 8,061.0000 | 31,150,000 | 9999.99% | 0.03% |
| May 29, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | M | SARs (Stock Appreciation Rights) | 1000 | $0.00 | 0.0000 | 31,150,000 | 100.00% | 0.00% |
| May 29, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | F | Common Stock | 966 | $57.69 | 16,380.0000 | 31,150,000 | 5.57% | 0.00% |
| May 29, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | M | Common Stock | 1000 | $55.70 | 17,346.0000 | 31,150,000 | 6.12% | 0.00% |
| May 5, 2025 | CONMED Corp | $CNMD | Farkas Charles | Director | S | Common Stock | 4000 | $56.94 | 16,346.0000 | 31,150,000 | 19.66% | 0.01% |
| Sept. 5, 2024 | CONMED Corp | $CNMD | Farkas Charles | Director | M | SARs (Stock Appreciation Rights) | 1000 | $0.00 | 0.0000 | 31,548,000 | 100.00% | 0.00% |
| Sept. 5, 2024 | CONMED Corp | $CNMD | Farkas Charles | Director | F | Common Stock | 534 | $74.31 | 20,346.0000 | 31,548,000 | 2.56% | 0.00% |
| Sept. 5, 2024 | CONMED Corp | $CNMD | Farkas Charles | Director | M | Common Stock | 1000 | $39.64 | 20,880.0000 | 31,548,000 | 5.03% | 0.00% |
| June 3, 2024 | CONMED Corp | $CNMD | Farkas Charles | Director | A | Options To Purchase Common Stock | 5503 | $0.00 | 5,503.0000 | 31,548,000 | 9999.99% | 0.02% |
| June 3, 2024 | CONMED Corp | $CNMD | Farkas Charles | Director | A | Rsus (restricted Stock Units) | 479 | $0.00 | 479.0000 | 31,548,000 | 9999.99% | 0.00% |
| May 31, 2024 | CONMED Corp | $CNMD | Farkas Charles | Director | M | Common Stock | 302 | $0.00 | 19,880.0000 | 31,548,000 | 1.54% | 0.00% |
| May 31, 2024 | CONMED Corp | $CNMD | Farkas Charles | Director | M | Rsus (restricted Stock Units) | 302 | $0.00 | 0.0000 | 31,548,000 | 100.00% | 0.00% |